Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  91 results for ""Antibodies, Monoclonal""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review.

  • Authors : Kelsen SG; Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA. .; Maurer M

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/immunology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: Respiratory research [Respir Res] 2025 Oct 29; Vol. 26 (1), pp. 302. Date of Electronic Publication: 2025 Oct 29.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.

  • Authors : Budda B; Alector, Inc, 131 Oyster Point Blvd, #600, South San Francisco, CA, 94080, USA. .; Mitra A

Subjects: Progranulins*/Progranulins*/Progranulins*/metabolism ; Progranulins*/Progranulins*/Progranulins*/blood ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Jul 25; Vol. 17 (1), pp. 174. Date of Electronic Publication: 2025 Jul 25.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Aducanumab binds high molecular weight soluble Aβ oligomers and restores intracellular calcium levels.

  • Authors : Yu L; Department of Neurology, MassGeneral Institute of Neurodegenerative Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown Boston, MA, 02129, USA.; Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.

Subjects: Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/metabolism ; Calcium*/Calcium*/Calcium*/metabolism ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Aug 04; Vol. 17 (1), pp. 180. Date of Electronic Publication: 2025 Aug 04.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

Record details

×
Editorial & Opinion

Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance.

  • Authors : Donati M; Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.; Boccia A

Subjects: Pharmacovigilance* ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Apr 11; Vol. 17 (1), pp. 80. Date of Electronic Publication: 2025 Apr 11.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Lecanemab in clinical practice: real-world outcomes in early Alzheimer's disease.

  • Authors : Bregman N; Cognitive Neurology Unit, Neurological Institute, Tel-Aviv Medical Center, 6 Weizmann St., Tel Aviv, 6423906, Israel. .; Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, 6997801, Israel. .

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/diagnostic imaging ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 May 28; Vol. 17 (1), pp. 119. Date of Electronic Publication: 2025 May 28.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Novel fully human high-affinity anti-TREM2 antibody shows efficacy in clinically relevant Alzheimer´s mouse model.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/immunology

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 May 22; Vol. 17 (1), pp. 114. Date of Electronic Publication: 2025 May 22.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.

  • Authors : Caminati M; Allergy Unit and Asthma Center, Integrated University Hospital of Verona, Verona, Italy. .; Department of Medicine, University of Verona, Verona, Italy. .

Subjects: Anti-Asthmatic Agents*/Anti-Asthmatic Agents*/Anti-Asthmatic Agents*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Asthma*/Asthma*/Asthma*/drug therapy

  • Source: Respiratory research [Respir Res] 2024 Oct 09; Vol. 25 (1), pp. 367. Date of Electronic Publication: 2024 Oct 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer's disease.

  • Authors : Arastoo M; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Scottish Biologics Facility, University of Aberdeen, Aberdeen, UK.

Subjects: tau Proteins*/tau Proteins*/tau Proteins*/immunology ; tau Proteins*/tau Proteins*/tau Proteins*/metabolism ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/immunology

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Oct 02; Vol. 16 (1), pp. 209. Date of Electronic Publication: 2024 Oct 02.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium:

Record details

×
Report

Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Asthma*/Asthma*/Asthma*/diagnosis ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: Respiratory research [Respir Res] 2024 Jul 11; Vol. 25 (1), pp. 272. Date of Electronic Publication: 2024 Jul 11.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Tumor mutational burden adjusted by neutrophil-to-lymphocyte ratio serves as a potential biomarker for atezolizumab-treated patients with extensive stage small cell lung cancer.

  • Authors : Zhang C; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

Subjects: Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/drug therapy ; Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/blood ; Neutrophils*

  • Source: Respiratory research [Respir Res] 2024 Jun 21; Vol. 25 (1), pp. 253. Date of Electronic Publication: 2024 Jun 21.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-10 of  91 results for ""Antibodies, Monoclonal""